Immunocore Holdings
NasdaqGS:IMCR Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
AN
Consensus Narrative from 14 Analysts
AI Tools And Global Expansion Will Broaden KIMMTRAK's Market Reach
Key Takeaways Expansion into less dense U.S. markets and international launches are key to driving revenue growth for Immunocore's KIMMTRAK. Strong financial position and diverse clinical pipeline position Immunocore for future revenue growth and increased net margins.
View narrativeUS$64.03
FV
53.7% undervalued intrinsic discount12.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
2 days ago author updated this narrative